Dermata Therapeutics, Inc. Profile Avatar - Palmy Investing

Dermata Therapeutics, Inc.

Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions. The company's lead product candidate…

Biotechnology
US, San Diego [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Dermata Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Dermata Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Dermata Therapeutics, Inc..

End of DRMA's Analysis
CIK: 1853816 CUSIP: 249845108 ISIN: US2498453065 LEI: - UEI: -
Secondary Listings
DRMA has no secondary listings inside our databases.